title: TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.
abstract: BACKGROUND
  Cervical cancer is caused primarily by human papillomaviruses (HPV). The polymorphism rs1042522 at codon 72 of the TP53 tumour-suppressor gene has been investigated as a genetic cofactor. More than 80 studies were done between 1998 and 2006, after it was initially reported that women who are homozygous for the arginine allele had a risk for cervical cancer seven times higher than women who were heterozygous for the allele. However, results have been inconsistent. Here we analyse pooled data from 49 studies to determine whether there is an association between TP53 codon 72 polymorphism and cervical cancer.
  
  
  METHODS
  Individual data on 7946 cases and 7888 controls from 49 different studies worldwide were reanalysed. Odds ratios (OR) were estimated using logistic regression, stratifying by study and ethnic origin. Subgroup analyses were done for infection with HPV, ethnic origin, Hardy-Weinberg equilibrium, study quality, and the material used to determine TP53 genotype.
  
  
  RESULTS
  The pooled estimates (OR) for invasive cervical cancer were 1.22 (95% CI 1.08-1.39) for arginine homozygotes compared with heterozygotes, and 1.13 (0.94-1.35) for arginine homozygotes versus proline homozygotes. Subgroup analyses showed significant excess risks only in studies where controls were not in Hardy-Weinberg equilibrium (1.71 [1.21-2.42] for arginine homozygotes compared with heterozygotes), in non-epidemiological studies (1.35 [1.15-1.58] for arginine homozygotes compared with heterozygotes), and in studies where TP53 genotype was determined from tumour tissue (1.39 [1.13-1.73] for arginine homozygotes compared with heterozygotes). Null results were noted in studies with sound epidemiological design and conduct (1.06 [0.87-1.29] for arginine homozygotes compared with heterozygotes), and studies in which TP53 genotype was determined from white blood cells (1.06 [0.87-1.29] for arginine homozygotes compared with heterozygotes).
  
  
  CONCLUSIONS
  Subgroup analyses indicated that excess risks were most likely not due to clinical or biological factors, but to errors in study methods. No association was found between cervical cancer and TP53 codon 72 polymorphism when the analysis was restricted to methodologically sound studies.
  
  
  BACKGROUND
  German Research Foundation (DFG).
authors.affiliation: Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes Gutenberg-University of Mainz, Mainz, Germany. klug@imbei.uni-mainz.de
authors.forename: Stefanie J
authors.initials: SJ
authors.lastname: Klug
authors.forename: Meike
authors.initials: M
authors.lastname: Ressing
authors.forename: Jochem
authors.initials: J
authors.lastname: Koenig
authors.forename: Martin C
authors.initials: MC
authors.lastname: Abba
authors.forename: Theodoros
authors.initials: T
authors.lastname: Agorastos
authors.forename: Sylvia M F
authors.initials: SM
authors.lastname: Brenna
authors.forename: Marco
authors.initials: M
authors.lastname: Ciotti
authors.forename: B R
authors.initials: BR
authors.lastname: Das
authors.forename: Annarosa
authors.initials: A
authors.lastname: Del Mistro
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Dybikowska
authors.forename: Anna R
authors.initials: AR
authors.lastname: Giuliano
authors.forename: Zivile
authors.initials: Z
authors.lastname: Gudleviciene
authors.forename: Ulf
authors.initials: U
authors.lastname: Gyllensten
authors.forename: Andrea L F
authors.initials: AL
authors.lastname: Haws
authors.forename: Aslaug
authors.initials: A
authors.lastname: Helland
authors.forename: C Simon
authors.initials: CS
authors.lastname: Herrington
authors.forename: Alan
authors.initials: A
authors.lastname: Hildesheim
authors.forename: Olivier
authors.initials: O
authors.lastname: Humbey
authors.forename: Sun H
authors.initials: SH
authors.lastname: Jee
authors.forename: Jae Weon
authors.initials: JW
authors.lastname: Kim
authors.forename: Margaret M
authors.initials: MM
authors.lastname: Madeleine
authors.forename: Joseph
authors.initials: J
authors.lastname: Menczer
authors.forename: Hextan Y S
authors.initials: HY
authors.lastname: Ngan
authors.forename: Akira
authors.initials: A
authors.lastname: Nishikawa
authors.forename: Yoshimitsu
authors.initials: Y
authors.lastname: Niwa
authors.forename: Rosemary
authors.initials: R
authors.lastname: Pegoraro
authors.forename: M R
authors.initials: MR
authors.lastname: Pillai
authors.forename: Gulielmina
authors.initials: G
authors.lastname: Ranzani
authors.forename: Giovanni
authors.initials: G
authors.lastname: Rezza
authors.forename: Adam N
authors.initials: AN
authors.lastname: Rosenthal
authors.forename: Susanta
authors.initials: S
authors.lastname: Roychoudhury
authors.forename: Dhananjaya
authors.initials: D
authors.lastname: Saranath
authors.forename: Virginia M
authors.initials: VM
authors.lastname: Schmitt
authors.forename: Sharmila
authors.initials: S
authors.lastname: Sengupta
authors.forename: Wannapa
authors.initials: W
authors.lastname: Settheetham-Ishida
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shirasawa
authors.forename: Peter J F
authors.initials: PJ
authors.lastname: Snijders
authors.forename: Mark H
authors.initials: MH
authors.lastname: Stoler
authors.forename: Angel E
authors.initials: AE
authors.lastname: Suárez-Rincón
authors.forename: Krisztina
authors.initials: K
authors.lastname: Szarka
authors.forename: Ruth
authors.initials: R
authors.lastname: Tachezy
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Ueda
authors.forename: Ate G J
authors.initials: AG
authors.lastname: van der Zee
authors.forename: Magnus
authors.initials: M
authors.lastname: von Knebel Doeberitz
authors.forename: Ming-Tsang
authors.initials: MT
authors.lastname: Wu
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Yamashita
authors.forename: Ingeborg
authors.initials: I
authors.lastname: Zehbe
authors.forename: Maria
authors.initials: M
authors.lastname: Blettner
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D016158:Genes, p53; D020022:Genetic Predisposition to Disease; D006801:Humans; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000150:complications / Q000235:genetics; D011110:Polymorphism, Genetic; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000821:virology; D055815:Young Adult